dermatan sulfate has been researched along with alpha-L-Iduronidase Deficiency in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (36.59) | 18.7374 |
| 1990's | 1 (2.44) | 18.2507 |
| 2000's | 8 (19.51) | 29.6817 |
| 2010's | 14 (34.15) | 24.3611 |
| 2020's | 3 (7.32) | 2.80 |
| Authors | Studies |
|---|---|
| Millington, DS; Young, SP; Zhang, H | 1 |
| Beasley, J; Chen, AH; Dickson, PI; Le, SQ; McCaw, P; Millington, DS; Stiles, AR; Young, SP; Zhang, H | 1 |
| Cerón, M; Jiménez-Mariscal, JL; Peña-Gomar, I; Reyes-López, CA; Rosas-Trigueros, J | 1 |
| Ou, L; Przybilla, MJ; Whitley, CB | 1 |
| Boelens, JJ; Kuiper, GA; Langereis, EJ; van Hasselt, PM; Wijburg, FA | 1 |
| Abily-Donval, L; Afonso, C; Ausseil, J; Bekri, S; Brassier, A; De Lonlay, P; Gonzalez, BJ; Héron, B; Marret, S; Piraud, M; Schmitz-Afonso, I; Tebani, A; Vaz, FM; Zerimech, F | 1 |
| Bailey, DB; Bali, D; Beckloff, SE; Clinard, K; Gehtland, LM; Kemper, AR; Lee, S; Millington, D; Muenzer, J; Patel, HS; Powell, CM; Rehder, C; Shone, SM; Taylor, JL; Woodell, C; Young, SP; Zimmerman, SJ | 1 |
| Maita, N; Ohno, K; Saito, S; Sakuraba, H; Taniguchi, H; Taniguchi, T; Tsukimura, T | 1 |
| Bigger, BW; Church, HJ; Geskus, RB; Hollak, CE; Jones, SA; Kulik, W; Langereis, EJ; Mercer, J; Schreider, L; Tylee, KL; van Lenthe, H; van Vlies, N; Wagemans, T; Wijburg, FA | 1 |
| Cammarata-Scalisi, F; Chávez, CJ; Delgado Luengo, WN; Miranda Contreras, LE; Solis-Añez, E | 1 |
| Bodamer, OA; Dajnoki, A; Johnson, BA | 1 |
| Bigger, BW; Church, HJ; Mercer, J; O'Meara, A; Thornley, M; Tylee, K; Wraith, JE; Wynn, RF | 1 |
| Arasaradnam, M; Bigger, BW; Langford-Smith, K; Wraith, JE; Wynn, R | 1 |
| Barrera, L; de Carvalho, TG; Dung, VC; Fukushi, M; Gutiérrez, ML; Kida, K; Kubota, M; Montaño, AM; Oguma, T; Oikawa, H; Orii, T; Sakura, N; Suzuki, Y; Tomatsu, S; Yamaguchi, S | 1 |
| An, Y; Auray-Blais, C; Bhérer, P; Clarke, JT; Gagnon, R; Millington, DS; Young, SP; Zhang, HH | 1 |
| Auray-Blais, C; Millington, DS; Orchard, PJ; Tolar, J; Young, SP; Zhang, H | 1 |
| Bigger, BW; de Ru, MH; Hollak, CE; Ijlst, L; Kulik, W; Saif, MA; van der Tol, L; van der Wal, WM; van Lenthe, H; van Vlies, N; Wagemans, T; Wanders, RJ; Wijburg, FA | 1 |
| de Ru, MH; de Ruijter, J; Ijlst, L; Lund, AM; Orchard, PJ; Schaefer, GB; van Vlies, N; Wagemans, T; Wijburg, FA | 1 |
| Fuller, M; Hopwood, JJ; Meikle, PJ | 1 |
| Brooks, DA; Evangelista, M; Fuller, M; Hein, LK; Hopwood, JJ; Meikle, PJ | 1 |
| Braga, LM; Burin, M; Camassola, M; Dalberto, TP; Delgado-Cañedo, A; Giugliani, R; Matte, U; Nardi, NB | 1 |
| Baxter, MA; Bellantuono, I; Fairbairn, LJ; Holmes, DK; Schyma, L; Wraith, JE; Wynn, RF | 1 |
| Carr, T; Church, H; Cooper, A; Mercer, J; O'Meara, A; Thornley, M; Tylee, K; Wraith, E; Wynn, RF | 1 |
| Castro, JZ; Costa, MG; Giugliani, ER; Giugliani, R; Wajner, M; Wannmacher, CM | 1 |
| Isemura, M; Ototani, N; Satake, S; Yosizawa, Z | 1 |
| Hopwood, JJ; Muller, VJ | 1 |
| Hayashi, S; Kimura, A; Koseki, M; Tsurumi, K | 1 |
| Benson, PF; Der Kaloustian, VM; Dudin, G; Fensom, AH; Mossman, J; Patrick, AD; Tansley, LR | 1 |
| Ikeno, T; Minami, R; Nakao, T; Tsugawa, S | 1 |
| Hinek, A; Wilson, SE | 1 |
| Barone, R; Fiumara, A; Parano, E; Pavone, P; Trifiletti, RR | 1 |
| Ikenaka, T; Isemura, M; Kido, R; Kosaka, H; Yoshimura, T | 1 |
| Constantopoulos, G; Dekaban, AS | 2 |
| Cunningham, WL; Ramage, P | 1 |
| Ferrans, VJ; Rentería, VG | 1 |
| Dorfman, A; Matalon, R | 1 |
| Constantopoulos, G; Dekaban, AS; Herman, MM; Steusing, JK | 1 |
| Meyer, HJ; Naumann, GO; Rummelt, V | 1 |
| Constantopoulos, G; Scott, JA; Shull, RM | 1 |
| Bezou, MJ; Demeocq, F; Malpuech, G; Meyer, M; Storme, B; Tiget, F; Viallard, JL | 1 |
1 trial(s) available for dermatan sulfate and alpha-L-Iduronidase Deficiency
| Article | Year |
|---|---|
Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy.
Topics: Biomarkers; Chondroitin Sulfates; Dermatan Sulfate; Enzyme Therapy; Enzymes; Hematopoietic Stem Cell Transplantation; Humans; Mucopolysaccharidosis I; Mucopolysaccharidosis II; Mucopolysaccharidosis VI | 2009 |
40 other study(ies) available for dermatan sulfate and alpha-L-Iduronidase Deficiency
| Article | Year |
|---|---|
Quantification of Glycosaminoglycans in Urine by Isotope-Dilution Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry.
Topics: Chondroitin Sulfates; Chromatography, Liquid; Dermatan Sulfate; Glycosaminoglycans; Heparitin Sulfate; Humans; Iduronic Acid; Isotopes; Mucopolysaccharidoses; Mucopolysaccharidosis I; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2023 |
Comparison of dermatan sulfate and heparan sulfate concentrations in serum, cerebrospinal fluid and urine in patients with mucopolysaccharidosis type I receiving intravenous and intrathecal enzyme replacement therapy.
Topics: Chromatography, Liquid; Dermatan Sulfate; Enzyme Replacement Therapy; Glycosaminoglycans; Heparitin Sulfate; Humans; Mucopolysaccharidosis I; Tandem Mass Spectrometry | 2020 |
c.1898C>G/p.Ser633Trp Mutation in Alpha-L-Iduronidase: Clinical and Structural Implications.
Topics: Abnormalities, Multiple; Catalytic Domain; Crystallography, X-Ray; Dermatan Sulfate; Enzyme Replacement Therapy; Gene Expression; Heparitin Sulfate; Humans; Iduronidase; Infant; Male; Molecular Dynamics Simulation; Mucopolysaccharidosis I; Point Mutation; Principal Component Analysis; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Substrate Specificity | 2021 |
Phenotype prediction for mucopolysaccharidosis type I by in silico analysis.
Topics: Algorithms; Dermatan Sulfate; Genotype; Glycosaminoglycans; Humans; Iduronidase; Mucopolysaccharidosis I; Phenotype; Polymorphism, Single Nucleotide | 2017 |
Incomplete biomarker response in mucopolysaccharidosis type I after successful hematopoietic cell transplantation.
Topics: Biomarkers; Cell Transplantation; Child; Child, Preschool; Chromatography, Liquid; Dermatan Sulfate; Female; Hematopoietic Stem Cell Transplantation; Heparitin Sulfate; Humans; Infant; Infant, Newborn; Male; Mucopolysaccharidosis I; Tandem Mass Spectrometry | 2017 |
Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling.
Topics: Adolescent; Adult; Aged; Algorithms; Amino Acids; Arginine; Case-Control Studies; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dermatan Sulfate; Female; Glutathione; Heparitin Sulfate; Humans; Infant; Keratan Sulfate; Male; Mass Spectrometry; Metabolome; Metabolomics; Middle Aged; Mucopolysaccharidosis I; Multivariate Analysis; Phenotype; Proline | 2017 |
The North Carolina Experience with Mucopolysaccharidosis Type I Newborn Screening.
Topics: Algorithms; Dermatan Sulfate; Genetic Testing; Genetic Variation; Glycosaminoglycans; Heparitin Sulfate; Humans; Iduronidase; Infant, Newborn; Mucopolysaccharidosis I; Neonatal Screening; North Carolina; Referral and Consultation; Sequence Analysis; Tandem Mass Spectrometry | 2019 |
Human α-L-iduronidase uses its own N-glycan as a substrate-binding and catalytic module.
Topics: Amino Acid Sequence; Binding Sites; Biocatalysis; Circular Dichroism; Crystallography, X-Ray; Dermatan Sulfate; Electrophoresis, Polyacrylamide Gel; Heparitin Sulfate; Humans; Iduronidase; Kinetics; Mannose; Models, Molecular; Molecular Sequence Data; Mucopolysaccharidosis I; Mutation; Polysaccharides; Protein Binding; Protein Structure, Tertiary; Sequence Homology, Amino Acid; Substrate Specificity | 2013 |
Biomarker responses correlate with antibody status in mucopolysaccharidosis type I patients on long-term enzyme replacement therapy.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Dermatan Sulfate; Disaccharides; Enzyme Replacement Therapy; Female; Follow-Up Studies; Heparin Cofactor II; Heparitin Sulfate; Humans; Iduronidase; Immunoglobulin G; Infant; Infant, Newborn; Male; Mucopolysaccharidosis I; Recombinant Proteins; Thrombin; Young Adult | 2015 |
Mutation c.1190-1delG/N in intron 8 and c.1708G>C/N in exon 12 not reported in the IDUA gene developed a clinical phenotype of Scheie syndrome.
Topics: Adult; Amino Acid Substitution; Dermatan Sulfate; Disease Progression; Exons; Glycosaminoglycans; Hand Deformities, Acquired; Heterozygote; Humans; Iduronidase; Introns; Magnetic Resonance Imaging; Male; Mucopolysaccharidosis I; Mutation, Missense; Phenotype; Point Mutation; Sequence Deletion; Spinal Cord Compression; Symptom Assessment | 2014 |
Diagnosing lysosomal storage disorders: mucopolysaccharidosis type I.
Topics: Dermatan Sulfate; Dried Blood Spot Testing; Enzyme Replacement Therapy; Gene Expression; Heparitin Sulfate; Humans; Iduronidase; Infant; Infant, Newborn; Leukocytes, Mononuclear; Mucopolysaccharidosis I; Mutation; Neonatal Screening; Tandem Mass Spectrometry | 2015 |
Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice.
Topics: Animals; Biomarkers; Blood Specimen Collection; Dermatan Sulfate; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Heparin Cofactor II; Heparitin Sulfate; Humans; Mice; Mice, Inbred C57BL; Mucopolysaccharidosis I; Mucopolysaccharidosis III; Thrombin | 2010 |
Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Chromatography, Liquid; Dermatan Sulfate; Enzyme-Linked Immunosorbent Assay; Female; Heparitin Sulfate; Humans; Infant, Newborn; Male; Mass Screening; Mucopolysaccharidosis I; Neonatal Screening; Tandem Mass Spectrometry; Young Adult | 2010 |
Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI.
Topics: Adolescent; Adult; Biomarkers; Case-Control Studies; Child; Child, Preschool; Chromatography, Liquid; Creatinine; Dermatan Sulfate; Enzyme Replacement Therapy; Female; Glycosaminoglycans; Heparitin Sulfate; Humans; Infant; Male; Mucopolysaccharidosis I; Mucopolysaccharidosis II; Mucopolysaccharidosis VI; Reference Values; Tandem Mass Spectrometry; Young Adult | 2011 |
Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry.
Topics: Biomarkers; Calibration; Child; Chondroitin Sulfates; Chromatography, High Pressure Liquid; Dermatan Sulfate; Deuterium; Dimerization; Enzyme Replacement Therapy; Hematopoietic Stem Cell Transplantation; Heparitin Sulfate; Hexosamines; Humans; Indicator Dilution Techniques; Injections, Intravenous; Injections, Spinal; Mucopolysaccharidosis I; Reference Standards; Reference Values; Tandem Mass Spectrometry; Uronic Acids | 2011 |
Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans.
Topics: Adolescent; Adult; Aged; Biomarkers; Child; Child, Preschool; Dermatan Sulfate; Disaccharides; Enzyme Replacement Therapy; Female; Glycosaminoglycans; Heparitin Sulfate; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mucopolysaccharidosis I; Young Adult | 2013 |
Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
Topics: Biomarkers; Child; Child, Preschool; Dermatan Sulfate; Disaccharides; Heparitin Sulfate; Humans; Infant; Infant, Newborn; Mucopolysaccharidoses; Mucopolysaccharidosis I; Mucopolysaccharidosis II; Mucopolysaccharidosis III; Neonatal Screening; Reproducibility of Results; Tandem Mass Spectrometry | 2012 |
Glycosaminoglycan degradation fragments in mucopolysaccharidosis I.
Topics: Animals; Cells, Cultured; Cricetinae; Dermatan Sulfate; Fibroblasts; Glucuronidase; Glycosaminoglycans; Heparitin Sulfate; Humans; Iduronic Acid; Iduronidase; Mucopolysaccharidosis I; Skin; Spectrometry, Mass, Electrospray Ionization | 2004 |
Prediction of neuropathology in mucopolysaccharidosis I patients.
Topics: Adolescent; Adult; Cells, Cultured; Central Nervous System; Child; Child, Preschool; Dermatan Sulfate; Fibroblasts; Forecasting; Genotype; Heparitin Sulfate; Humans; Iduronidase; Infant; Mass Spectrometry; Mucopolysaccharidosis I; Oligosaccharides; Phenotype; Skin | 2005 |
Nonviral in vivo gene transfer in the mucopolysaccharidosis I murine model.
Topics: Animals; Bone Marrow Transplantation; Dermatan Sulfate; Disease Models, Animal; DNA, Complementary; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Glycosaminoglycans; Heparitin Sulfate; Humans; Lysosomes; Mice; Mice, Inbred C57BL; Mice, Knockout; Mucopolysaccharidosis I; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Distribution; Transduction, Genetic; Transfection | 2005 |
Marrow stromal cells from patients affected by MPS I differentially support haematopoietic progenitor cell development.
Topics: Adolescent; Antigens, CD34; Bone Marrow; Bone Marrow Cells; Cell Adhesion; Cell Proliferation; Cells, Cultured; Child; Child, Preschool; Collagen; Dermatan Sulfate; Hematopoietic Stem Cells; Heparitin Sulfate; Humans; Iduronidase; Infant; Mucopolysaccharidosis I; Stem Cells; Stromal Cells; Time Factors | 2005 |
Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease.
Topics: Chimerism; Chondroitin Sulfates; Cord Blood Stem Cell Transplantation; Dermatan Sulfate; Glycosaminoglycans; Hematopoietic Stem Cell Transplantation; Heterozygote; Histocompatibility Testing; Humans; Iduronidase; Mucopolysaccharidosis I; Transplantation, Homologous; Treatment Outcome | 2007 |
Clinical and biochemical effects of long-term vitamin A administration to a patient with Hurler-Scheie compound.
Topics: Adolescent; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Female; Glycosaminoglycans; Heparitin Sulfate; Humans; Mucopolysaccharidosis I; Syndrome; Vitamin A | 1984 |
Enzymatic determination of urinary glycosaminoglycans from orthopedic patients.
Topics: Adolescent; Adult; Aged; Bone Diseases; Chemical Fractionation; Chondroitin Sulfates; Dermatan Sulfate; Female; Glucuronidase; Glycosaminoglycans; Heparitin Sulfate; Humans; Hyaluronic Acid; Lyases; Male; Middle Aged; Mucopolysaccharidosis I; Werner Syndrome | 1983 |
alpha-L-Iduronidase deficiency in mucopolysaccharidosis type I against a radiolabelled sulfated disaccharide substrate derived from dermatan sulfate.
Topics: Amniotic Fluid; Cells, Cultured; Chondroitin; Dermatan Sulfate; Disaccharides; Glycoside Hydrolases; Humans; Iduronidase; Kinetics; Leukocytes; Mucopolysaccharidosis I; Prenatal Diagnosis; Skin; Structure-Activity Relationship; Substrate Specificity | 1984 |
Characteristics of urinary glycosaminoglycans excreted by a patient with the Hurler-Scheie compound syndrome.
Topics: Dermatan Sulfate; Glycosaminoglycans; Heparitin Sulfate; Humans; Molecular Weight; Mucopolysaccharidosis I | 1982 |
Correct prenatal diagnosis of a Hurler fetus where amniotic fluid cell cultures were of maternal origin.
Topics: Amniotic Fluid; Cells, Cultured; Chondroitin; Dermatan Sulfate; Electrophoresis; Female; Glycoside Hydrolases; Humans; Iduronidase; Infant, Newborn; Male; Mucopolysaccharidosis I; Pregnancy; Prenatal Diagnosis | 1981 |
Acidic glycosaminoglycans and gangliosides in the brains from four patients with genetic mucopolysaccharidosis.
Topics: Adolescent; Brain; Brain Chemistry; Child; Child, Preschool; Dermatan Sulfate; Fetus; Gangliosides; Glycosaminoglycans; Humans; Infant; Keratan Sulfate; Mucopolysaccharidosis I; Mucopolysaccharidosis II; Mucopolysaccharidosis IV | 1982 |
Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly.
Topics: Adolescent; Cell Count; Cell Division; Cells, Cultured; Child; Child, Preschool; Coronary Vessels; Dermatan Sulfate; Elastic Tissue; Elastin; Female; Fetus; Fibroblasts; Fibronectins; Fluorescent Antibody Technique, Indirect; Heparitin Sulfate; Humans; Infant; Male; Mitral Valve; Mucopolysaccharidosis I; Mucopolysaccharidosis III; Receptors, Cell Surface; Skin; Tropoelastin | 2000 |
White matter changes mimicking a leukodystrophy in a patient with Mucopolysaccharidosis: characterization by MRI.
Topics: Adolescent; Atrophy; Bone and Bones; Bone Diseases, Metabolic; Brain; Cerebral Ventricles; Cognition Disorders; Dermatan Sulfate; Diagnosis, Differential; Female; Heparitin Sulfate; Humans; Iduronidase; Leukodystrophy, Globoid Cell; Magnetic Resonance Imaging; Mucopolysaccharidosis I; Nerve Fibers, Myelinated; Phenotype | 2002 |
Fluorometric measurement of urinary alpha-L-iduronidase activity.
Topics: Adult; Child, Preschool; Dermatan Sulfate; Female; Fluorometry; Glycoside Hydrolases; Heparitin Sulfate; Humans; Hymecromone; Iduronic Acid; Iduronidase; Male; Middle Aged; Mucopolysaccharidoses; Mucopolysaccharidosis I | 1978 |
Chemical definition of the mucopolysaccharidoses.
Topics: Adolescent; Adult; Bone and Bones; Carbohydrate Metabolism, Inborn Errors; Child; Child, Preschool; Chondroitin; Dermatan Sulfate; Female; Glycosaminoglycans; Heparitin Sulfate; Humans; Hypertrichosis; Infant; Intellectual Disability; Joint Diseases; Male; Mucopolysaccharidoses; Mucopolysaccharidosis I; Mucopolysaccharidosis II; Retinitis Pigmentosa | 1975 |
Comparative structural studies of urinary glycosaminoglycans in the Hurler and Hunter syndromes.
Topics: Child; Dermatan Sulfate; Female; Galactosamine; Glucosamine; Glycosaminoglycans; Humans; Male; Mucopolysaccharidosis I; Mucopolysaccharidosis II; Sulfuric Acids; Uronic Acids | 1975 |
Intracellular collagen fibrils in cardiac valves of patients with the Hurler syndrome.
Topics: Child; Collagen; Connective Tissue; Cytoplasmic Granules; Dermatan Sulfate; Female; Fibroblasts; Glycosaminoglycans; Heart Valve Diseases; Humans; Male; Mitral Valve; Mucopolysaccharidosis I; Tricuspid Valve | 1976 |
Mucopolysaccharidosis type I, II, IIIA and V. Pathological and biochemical abnormalities in the neural and mesenchymal elements of the brain.
Topics: Adult; Brain; Brain Chemistry; Child; Connective Tissue; Connective Tissue Cells; Dermatan Sulfate; Glycosaminoglycans; Humans; Meninges; Microscopy, Electron; Mucopolysaccharidoses; Mucopolysaccharidosis I; Mucopolysaccharidosis II; Mucopolysaccharidosis III; Neurons | 1977 |
The mucopolysaccharidoses (a review).
Topics: Acetylglucosaminidase; Alleles; Arylsulfatases; Chondroitin Sulfates; Dermatan Sulfate; Glucuronidase; Glycosaminoglycans; Heparitin Sulfate; History, 20th Century; Humans; Iduronidase; Mucopolysaccharidoses; Mucopolysaccharidosis I; Sulfatases | 1976 |
Mucopolysaccharidosis type V. (Scheie syndrome). A postmortem study by multidisciplinary techniques with emphasis on the brain.
Topics: Adult; Brain; Cerebral Cortex; Child; Dermatan Sulfate; Diagnosis, Differential; Female; Glycosaminoglycans; Heparitin Sulfate; Humans; Iduronidase; Liver; Male; Mucopolysaccharidoses; Mucopolysaccharidosis I; Mucopolysaccharidosis II | 1976 |
Light and electron microscopy of the cornea in systemic mucopolysaccharidosis type I-S (Scheie's syndrome).
Topics: Adult; Cornea; Dermatan Sulfate; Fibroblasts; Heparitin Sulfate; Humans; Iduronidase; Keratoplasty, Penetrating; Leukocytes; Male; Mucopolysaccharidosis I | 1992 |
Corneal opacity in canine MPS I. Changes after bone marrow transplantation.
Topics: Animals; Bone Marrow Transplantation; Corneal Opacity; Dermatan Sulfate; Dogs; Electrophoresis; Glycosaminoglycans; Keratan Sulfate; Mucopolysaccharidosis I; Time Factors | 1989 |
[Bone marrow allograft in Hurler's disease. Clinical and biological results after a 1 year's development].
Topics: Bone Marrow Transplantation; Child, Preschool; Dermatan Sulfate; Female; Humans; Iduronidase; Mucopolysaccharidosis I; Transplantation, Homologous | 1988 |